Abstract
We analyzed adverse events in a clinical phase I trial to assess dose-dependent metabolic effects of St. John’s wort co-administered with rifampicin in 12 healthy volunteers. Within 3–6 days after increasing the St. John’s wort dose from 300 to 600 mg TID, five of six female participants developed ambient temperature-dependent allodynia and paresthesia in sun-exposed areas (back of the hands and perioral and nasal area). Aggravation of symptoms resulted in persistence of paresthesia and phototoxic erythrodermia. None of the male participants showed any of these effects. Gender, duration of treatment, dose, and solar exposure seem to be extrinsic and host factors facilitating St. John’s wort-induced neuropathy. The risk to develop this adverse effect is almost exclusively present in women.
This is a preview of subscription content, log in via an institution to check access.
References
Bove GM (1998) Acute neuropathy after exposure to sun in a patient treated with St. John’s Wort. Lancet 352:1121–1122
Brockmöller J, Reum T, Bauer S, Kerb R, Hübner WD, Roots I (1997) Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30(Suppl. 2):94–101
Bundesinstitut für Arzneimittel und Medizinprodukte. Nebenwirkungsdatenbank des BfArM. http://nebenwirkung.bfarm.de/apex/f?p=100:1:0:::::. Accessed 23 Dec 2014
Fachinformation Jarsin(R) 300 mg. Stand: February 2011. Cassella-med, GmbH & Co. KG, Köln. Approval No.: 39112.00.00. http://www.fachinfo.de. Accessed 23 Dec 2014
Haefeli WE, Carls A (2014) Drug interactions with phytotherapeutics in oncology. Expert Opin Drug MetabToxicol 10:359–377
Hill K, Schaefer M (2009) Ultraviolet light and photosensitising agents activate TRPA1 via generation of oxidative stress. Cell Calcium 45:155–164
Knüppel L, Linde K (2004) Adverse effects of St. John’s wort: a systematic review. J Clin Psychiatry 65:1470–1479
Milligan ED, Penzkover KR, Soderquist RG, Mahoney MJ (2012) Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation 15:520–526 ; discussion 526
Onoue S, Seto Y, Ochi M, Inoue R, Ito H, Hatano T, Yamada S (2011) In vitro photochemical and phototoxicological characterization of major constituents in St. John’s Wort (Hypericum perforatum) extracts. Phytochemistry 72:1814–1820
Reeve VE, Allanson M, Domanski D, Painter N (2012) Gender differences in UV-induced inflammation and immunosuppression in mice reveal male unresponsiveness to UVA radiation. Photochem Photobiol Sci 11:173–179
Conflict of interest
No conflicts of interest are declared by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hohmann, N., Maus, A., Carls, A. et al. St. John’s wort treatment in women bears risks beyond pharmacokinetic drug interactions. Arch Toxicol 90, 1013–1015 (2016). https://doi.org/10.1007/s00204-015-1532-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-015-1532-7